appointments

Digital

This month's round-up spans clinical trial technology, drug discovery AI, genomics, bioelectrical medicine, CDMOs, and non-profits.

R&D

The pharmaceutical and biotech sectors have seen a flurry of executive movement this month.

News

Ipsen has appointed biopharma industry veteran Michelle Werner, who recently stepped down as CEO of Alltrna, to lead its North America division.

News

Lundbeck has appointed Markus Kede to the newly created role of chief AI officer, charged with driving its ambition to become a 'bionic' company.

News

Two long-serving pharma CEOs have announced their departures, as Sarepta's Doug Ingram and Alkermes' Richard Pops announce their retirement.

News

Daiichi Sankyo has named John Tsai as its new global head of R&D, replacing Ken Takeshita, who is stepping down after five years in the role.